Anixa Biosciences Inc. (ANIX)
NASDAQ: ANIX
· Real-Time Price · USD
3.02
0.05 (1.68%)
At close: Aug 18, 2025, 3:57 PM
3.04
0.78%
After-hours: Aug 18, 2025, 07:41 PM EDT
1.68% (1D)
| Bid | 2.98 |
| Market Cap | 97.12M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -12.13M |
| EPS (ttm) | -0.38 |
| PE Ratio (ttm) | -7.93 |
| Forward PE | -9.34 |
| Analyst | Buy |
| Ask | 3.1 |
| Volume | 83,361 |
| Avg. Volume (20D) | 142,311 |
| Open | 3.02 |
| Previous Close | 2.97 |
| Day's Range | 2.97 - 3.05 |
| 52-Week Range | 2.07 - 4.20 |
| Beta | 0.44 |
About ANIX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ANIX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ANIX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+23.19%
Anixa Biosciences shares are trading higher after ...
Unlock content with
Pro Subscription
2 months ago
+12.45%
Anixa Biosciences shares are trading higher after the company announced it completed enrollment for its Phase 1 breast cancer vaccine clinical trial.
